entertainment -WSS

entertainment

author：fashion 2025-09-27 12:22:20 - browse：8365

Former MIT and Whitehead Institute star biologist David Sabatini, who lost his positions after he was accused of violating sexual harassment policies in 2021, is resuming his science career, taking a post at a Czech research institute in Prague.

Sabatini, of Cambridge, confirmed in a phone call from Prague that he has accepted a position as a “senior group leader” at the Institute of Organic Chemistry and Biochemistry, known as IOCB Prague. Sabatini said he will be recruiting staff and running a laboratory in the Czech Republic capital to investigate scientific questions in the areas of cell growth and metabolism, similar to his past research in Cambridge.

“I’m very grateful to be given the opportunity to do science again,” said Sabatini, who began working at the institute last month.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： It costs an awful lot of money to give away a kidney

explore

leisure time

WSS

FDA scientists endorse Pfizer/BioNTech Covid

Stanford president to resign after investigation of research

Resistance to cancer drugs: A new genetic explanation

Listen: Biotech layoffs, eye drug drama, & gene therapy milestones

The cancer stories no one wants to hear

TikTok cracks down on users posting about weight loss drugs

entertainment

entertainment

entertainment

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

'Reaching a detente': STAT's Helen Branswell on covering Covid

Supreme Court strikes down use of affirmative action

States increasingly look to regulate hospital facility fees

Sports medicine is finally prioritizing gender equality

When waiting feels immoral: Empathy in the emergency department

Guidelines to prevent youth baseball injuries need more muscle

FDA approves Sage Therapeutics’ rapid

Trump demands the U.S. pay no more for drugs than other countries … again

Seattle police shoot person suspected in downtown stabbing

entertainment

H.R. 3 is the wrong path to lower drug costs

FDA approves Sage Therapeutics’ rapid

India sets sights on home

The cancer stories no one wants to hear

Listen: Biotech layoffs, eye drug drama, & gene therapy milestones

How to ethically and practically extend health care to all

explore

leisure time

hotspot

knowledge